Product NDC: | 0378-2075 |
Proprietary Name: | Lisinopril |
Non Proprietary Name: | lisinopril |
Active Ingredient(s): | 20 mg/1 & nbsp; lisinopril |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-2075 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076071 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121005 |
Package NDC: | 0378-2075-01 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0378-2075-01) |
NDC Code | 0378-2075-01 |
Proprietary Name | Lisinopril |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0378-2075-01) |
Product NDC | 0378-2075 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lisinopril |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20121005 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | LISINOPRIL |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |